Literature DB >> 10355629

The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.

S Rentschler1, H Linn, K Deininger, M T Bedford, X Espanel, M Sudol.   

Abstract

Skeletal muscle dystrophin is a 427 kDa protein thought to act as a link between the actin cytoskeleton and the extracellular matrix. Perturbations of the dystrophin-associated complex, for example, between dystrophin and the transmembrane glycoprotein beta-dystroglycan, may lead to muscular dystrophy. Previously, the cysteine-rich region and first half of the carboxy-terminal domain of dystrophin were shown to interact with beta-dystroglycan through a stretch of fifteen amino acids at the carboxy-terminus of beta-dystroglycan. This region of dystrophin implicated in binding beta-dystroglycan contains four modular protein domains: a WW domain, two putative Ca2+-binding EF-hand motifs, and a putative zinc finger ZZ domain. The WW domain is a globular domain of 38-40 amino acids with two highly conserved tryptophan residues spaced 20-22 amino acids apart. A subset of WW domains was shown to bind ligands that contain a Pro-Pro-x-Tyr core motif (where x is any amino acid). Here we elucidate the role of the WW domain of dystrophin and surrounding sequence in binding beta-dystroglycan. We show that the WW domain of dystrophin along with the EF-hand motifs binds to the carboxy-terminus of beta-dystroglycan. Through site-specific mutagenesis and in vitro binding assays, we demonstrate that binding of dystrophin to the carboxy-terminus of beta-dystroglycan occurs via a beta-dystroglycan Pro-Pro-x-Tyr core motif. Targeted mutagenesis of conserved WW domain residues reveals that the dystrophin/beta-dystroglycan interaction occurs primarily through the WW domain of dystrophin. Precise mapping of this interaction could aid in therapeutic design.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355629     DOI: 10.1515/BC.1999.057

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  21 in total

1.  Direct interaction of beta-dystroglycan with F-actin.

Authors:  Yun-Ju Chen; Heather J Spence; Jacqueline M Cameron; Thomas Jess; Jane L Ilsley; Steven J Winder
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

2.  Salvador has an extended SARAH domain that mediates binding to Hippo kinase.

Authors:  Leah Cairns; Thao Tran; Brendan H Fowl; Angela Patterson; Yoo Jin Kim; Brian Bothner; Jennifer M Kavran
Journal:  J Biol Chem       Date:  2018-03-08       Impact factor: 5.157

Review 3.  The Dystrophin Complex: Structure, Function, and Implications for Therapy.

Authors:  Quan Q Gao; Elizabeth M McNally
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 4.  WWOX gene and gene product: tumor suppression through specific protein interactions.

Authors:  Zaidoun Salah; Rami Aqeilan; Kay Huebner
Journal:  Future Oncol       Date:  2010-02       Impact factor: 3.404

5.  A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy.

Authors:  Arjan P M de Brouwer; Sander B Nabuurs; Ingrid E C Verhaart; Astrid R Oudakker; Roel Hordijk; Helger G Yntema; Jannet M Hordijk-Hos; Krysta Voesenek; Bert B A de Vries; Ton van Essen; Wei Chen; Hao Hu; Jamel Chelly; Johan T den Dunnen; Vera M Kalscheuer; Annemieke M Aartsma-Rus; Ben C J Hamel; Hans van Bokhoven; Tjitske Kleefstra
Journal:  Eur J Hum Genet       Date:  2013-07-31       Impact factor: 4.246

6.  ZZ domain of dystrophin and utrophin: topology and mapping of a beta-dystroglycan interaction site.

Authors:  Karim Hnia; Dora Zouiten; Sonia Cantel; Delphine Chazalette; Gérald Hugon; Jean-Alain Fehrentz; Ahmed Masmoudi; Ann Diment; Janice Bramham; Dominique Mornet; Steve J Winder
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

7.  A role for the juxtamembrane domain of beta-dystroglycan in agrin-induced acetylcholine receptor clustering.

Authors:  Joanna Kahl; James T Campanelli
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

8.  L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.

Authors:  Karim Hnia; Jérôme Gayraud; Gérald Hugon; Michèle Ramonatxo; Sabine De La Porte; Stefan Matecki; Dominique Mornet
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

9.  Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.

Authors:  Rebecca E Vargas; Vy Thuy Duong; Han Han; Albert Paul Ta; Yuxuan Chen; Shiji Zhao; Bing Yang; Gayoung Seo; Kimberly Chuc; Sunwoo Oh; Amal El Ali; Olga V Razorenova; Junjie Chen; Ray Luo; Xu Li; Wenqi Wang
Journal:  EMBO J       Date:  2019-11-29       Impact factor: 11.598

10.  Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?

Authors:  Nils P J Vogtländer; Henk Jan Visch; Marinka A H Bakker; Jo H M Berden; Johan van der Vlag
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.